Heart disease is the leading cause of death worldwide. Current therapies have generally
proven either highly invasive or ineffective. Regenerative therapies for myocardial infarctions
have the potential to offer more successful and permanent solutions, however exhibit regular
obstacles. This paper reviews the current studies and obstinate difficulties that are yet to be
tackled with myocardial regenerative techniques for the purpose of converging focus on the
most promising therapeutic strategies. The urgent demand for long-term anatomical and
physiological compatibility is underlined.
The file is restricted for YU community access only.